Who should pay for gene therapy?

Posted by on May 26, 2016 7:19 pm
Categories: health

As gene therapy trials show promise to cure or ameliorate several diseases, it is time to explore ways to pay for the treatments, according to a new commentary. Noting the potential of gene therapy to be a one-time treatment for rare and serious diseases that otherwise cost hundreds of thousands, if not millions, of dollars in chronic care over a lifetime, the authors suggest several models for valuing, pricing and developing gene therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *